The following pages link to gender-affirming hormone therapy (Q27405):
Displayed 21 items.
- gender-affirming hormone therapy (Q2083) (← links)
- Primary care provider beliefs and knowledge of prescribing gender-affirming hormone therapy to transgender and gender diverse patients (Q27410) (← links)
- Bone health in transgender assigned female at birth people: effects of gender-affirming hormone therapy and gonadectomy (Q27579) (← links)
- Breast care considerations for transgender and gender-diverse patients (Q27660) (← links)
- Short-Term Changes in Bone Metabolism Among Transgender Men Starting Gender-Affirming Hormone Therapy: A Systematic Review and Meta-analysis (Q28562) (← links)
- Assessment of parenteral estradiol and dihydroxyprogesterone use among other feminizing regimens for transgender women: insights on satisfaction with breast development from community-based healthcare services (Q28781) (← links)
- Evaluating the Risk of Venous Thromboembolism in Transfeminine and Gender Diverse People: A Retrospective Analysis (Q29330) (← links)
- Safe and supportive prescribing in transgender and non-binary patients with cancer (Q29504) (← links)
- Gender-affirming hormonal therapy induces a gender-concordant fecal metagenome transition in transgender individuals (Q29540) (← links)
- Androgen Inhibition of Reproductive Neuroendocrine Function in Females and Transgender Males (Q29604) (← links)
- Transgender patients and gender-affirming hormone therapy through the mid-life (Q29890) (← links)
- Glomerular filtration rate estimation in transgender and gender-diverse adults using gender-affirming hormone therapy: an exploratory cross-sectional study (Q30289) (← links)
- (Q30639) (← links)
- (Q30726) (← links)
- (Q30832) (← links)
- (Q30912) (← links)
- (Q31140) (← links)
- (Q31472) (← links)
- (Q32050) (← links)
- (Q33547) (← links)
- (Q33669) (← links)